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Computational Design of β-Fluorinated
Morphine Derivatives for pH-speciﬁc Binding
By: Makena Augenstein, Nayiri Alexander, Angelina Sorensen, and Dr. Matthew Gartner
Schmid College of Science and Technology, Chapman University

Introduction

Methods

Opioids today remain eﬀective pain relievers,
but are highly addictive. In our research, we
propose a series of non-addictive opioid
derivatives that will bind preferentially in peripheral
tissue where inﬂammation occurs (pH = 6.5) and
not in physiological conditions (pH = 7.4).

Electronic structure calculations were optimized with GaussView 6 and computed with
Gaussian 16, Rev. B.01 using the Keck Computational Research Cluster at Chapman
University. From direct treatment of the aqueous phase reaction (1), we calculate the overall
change in Gibbs free energy for the aqueous deprotonation (2). The reported pKa values
are calculated using this reported change in free energy (3).

A pH-speciﬁc opioid derivative is aimed to induce
selective binding. The pH-sensitivity is attributed
to the addition of a ﬂuorine on a beta-carbon to
the ionic binding site, eﬀectively destabilizing the
amine group.

Discussion

(1) Morphine-H+(aq) → Morphine(aq) + H+(aq)

(3)

(2) ΔGaq= Gaq(Morphine) – Gaq(Morphine-H+) + Gaq(H+)

Results
Dissected Morphine

Morphine

The binding of the ﬂuoromorphine derivatives are
speciﬁc to peripheral opioid receptors within
inﬂamed tissue. Derivative will theoretically not
bind to opioid receptors located in the brain,
eﬀectively lessening the central nervous system
(CNS) response and lowering adverse side eﬀects.

D-ﬂuoromorphine β-C1

D-ﬂuoromorphine β-C2

C

Percent protonation is directly related to binding
aﬃnity. By keeping a high percent protonation in
inﬂamed tissue, binding in inﬂamed peripheral
tissues is encouraged while central opioid receptors
at physiological pH are not activated. The most
promising candidates are D-ﬂuoromorphine β-C1
and D-ﬂuoromorphine β-C2. Both structures
maintain high protonation in inﬂamed tissue, while
seeing a signiﬁcant decrease in percent protonation
in physiological tissue relative to morphine. The
dissected ring structure encourages high binding
aﬃnity, while the ﬂuorination beta to the binding site
promotes selectivity in inﬂamed tissue. This
encourages strong binding in sites of inﬂammation
and pain, while discouraging binding within central
tissues.

D
Tbl. 1. The table includes the computationally calculated pKa values of morphine, dissected morphine,
D-ﬂuoromorphine β-C1, and D-ﬂuoromorphine β-C2. The percent protonation of morphine, dissected morphine,
D-ﬂuoromorphine β-C1, and D-ﬂuoromorphine β-C2 at physiological (pH=7.4) and inﬂamed tissue (pH=6.5) are listed.

The benzomorphan drug class involves the dissection of
C and D rings of morphine (Tbl. 1 - Morphine); this
decreases the drug’s rigidity, which encourages a more
ﬁtted binding of the ligand to the receptor.
The proposed ﬂuoromorphine derivatives,
D-ﬂuoromorphine β-C1 and D-ﬂuoromorphine β-C2,
lack the C and D rings, similar to the benzomorphans.
We hypothesize that the combination of the induction by
ﬂuorine and proposed increase in binding aﬃnity will
allow the derivatives to preferentially bind in inﬂamed
tissue.

Morphine

Dissected
Morphine

Dﬂuoromorphine
β-C1

Dﬂuoromorphine
β-C2

pKa

8.2

9.54

7.83

7.04

Percent
protonation
(pH 7.4)

86.3

99.3

73.1

30.8

Next steps include using machine learning technology
to simulate ligand-receptor binding of the derivatives
to (1) the active site and (2) allosteric site of the
µ-opioid receptor. Preliminary data from simulations
will include basic binding aﬃnity, as well as
quantitative estimate of drug likeness (QED) and
synthetic accessibility scores (SAS) to ensure
derivatives remain realistic synthetic options to act on
drug targets.

Percent
protonation
(pH 6.5)

98.0

99.9

95.6

77.9
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